Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
6.49
-0.04 (-0.61%)
At close: Jun 5, 2025, 4:00 PM
6.51
+0.02 (0.31%)
After-hours: Jun 5, 2025, 4:00 PM EDT
Bioventus Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Bioventus stock ranges from a low of $13 to a high of $17. The average analyst price target of $15 forecasts a 131.12% increase in the stock price over the next year.
Price Target: $15.00 (+131.12%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 17, 2025.
Analyst Ratings
The average analyst rating for Bioventus stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 3 | 3 | 3 | 3 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 | Strong Buy | Maintains | $15 | +131.12% | Mar 17, 2025 |
JP Morgan | JP Morgan | Sell → Hold Upgrades $12 → $13 | Sell → Hold | Upgrades | $12 → $13 | +100.31% | Dec 17, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $12 → $15 | Strong Buy | Maintains | $12 → $15 | +131.12% | Nov 6, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $12 → $17 | Strong Buy | Maintains | $12 → $17 | +161.94% | Sep 27, 2024 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $8 → $12 | Strong Buy | Maintains | $8 → $12 | +84.90% | Aug 13, 2024 |
Financial Forecast
Revenue This Year
570.85M
from 573.28M
Decreased by -0.42%
Revenue Next Year
605.73M
from 570.85M
Increased by 6.11%
EPS This Year
0.66
from -0.52
EPS Next Year
0.90
from 0.66
Increased by 35.03%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 594.3M | 632.9M | 657.3M |
Avg | 570.9M | 605.7M | 632.3M |
Low | 553.4M | 584.1M | 613.5M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 3.7% | 10.9% | 8.5% |
Avg | -0.4% | 6.1% | 4.4% |
Low | -3.5% | 2.3% | 1.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 0.69 | 1.05 | 0.84 |
Avg | 0.66 | 0.90 | 0.81 |
Low | 0.64 | 0.72 | 0.78 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | 58.3% | -6.2% |
Avg | - | 35.0% | -9.8% |
Low | - | 7.9% | -12.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.